Tumor Updates: Glioblastoma Multiforme (GBM)

	https://www.ncbi.nlm.nih.gov/pubmed/28325264 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376454/ https://www.ncbi.nlm.nih.gov/pubmed/29209515 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866042/ https://www.ncbi.nlm.nih.gov/pubmed/26410343 https://www.ncbi.nlm.nih.gov/pubmed/28126644 https://www.ncbi.nlm.nih.gov/pubmed/27835750 https://www.ncbi.nlm.nih.gov/pubmed/29180881 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505128/ https://www.ncbi.nlm.nih.gov/pubmed/25720916 https://www.ncbi.nlm.nih.gov/pubmed/27889752 https://www.ncbi.nlm.nih.gov/pubmed/21434862 https://www.ncbi.nlm.nih.gov/pubmed/25738972 https://www.ncbi.nlm.nih.gov/pubmed/25069036	Updated Jan. 2018
	Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.	Updated Dec. 2013
	Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.	Updated Dec. 2013
	Glioblastoma management in the temozolomide era: have we improved outcome?	Updated Dec. 2013
	Bevacizumab for the treatment of glioblastoma.	Updated Dec. 2013
	Resection versus biopsy of glioblastomas in eloquent brain areas.	Updated Dec. 2013
	Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma.	Updated Dec. 2013
	Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.	Updated Dec. 2013
	Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population-based analysis.	Updated Dec. 2013
	Recurrent glioblastoma: Volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.	Updated Dec. 2013
	Gliomas of the pineal region.	Updated Dec. 2013
	An extent of resection threshold for newly diagnosed glioblastomas.
	Brain tumor headaches: from bedside to bench.
	Rapid development of glioblastoma at the site of atypical meningioma resection.
	Radiation-induced Glioblastoma Multiforme in Children Treated for Medulloblastoma With Characteristics of Both Medulloblastoma and Glioblastoma Multiforme.
	Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition cohort study.
	Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival.
	Temozolomide in malignant glioma.
	Prolonged administration of temozolomide in adult Prolonged administration of temozolomide in adultpatients with anaplastic glioma.
	Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.
	Towards personalized therapy for patients with glioblastoma..
	Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at first diagnosis.
	Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide.
	Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.
	Temozolomide in malignant glioma.
	Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival.
	Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition cohort study.
	Radiation-induced Glioblastoma Multiforme in Children Treated for Medulloblastoma With Characteristics of Both Medulloblastoma and Glioblastoma Multiforme.
	Rapid development of glioblastoma at the site of atypical meningioma resection.
	Brain tumor headaches: from bedside to bench.
	GBM Tumor Update: National Cancer Institute
	Radiation-Induced Malignant Gliomas: Is There a Role for Reirradiation?
	Repeated surgery for glioblastoma multiforme: Only in combinationwith other salvage therapy.
	Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years.2006 Mar-Apr;92(2):98-103.
	Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo.Neurosurgery. 2005;56(1):155-62; discussion 162.